Skip to main content
. Author manuscript; available in PMC: 2009 Apr 27.
Published in final edited form as: Hypertension. 2008 Feb 7;51(4):1190–1196. doi: 10.1161/HYPERTENSIONAHA.107.105627

Table.

Effect of Treatment on Baseline Characteristics

Parameter Placebo 17β-Estradiol P Value
Systolic blood pressure, mm Hg 112.0±3.1 110.3±2.7 0.584
Diastolic blood pressure, mm Hg 69.4±1.6 68.3±2.4 0.747
Mean arterial pressure, mm Hg 83.6±1.7 82.3±2.3 0.650
Heart rate, bpm 67.9±2.4 68.9±2.7 0.492
Baseline FBF, mL/min per 100 mL 3.6±0.6 4.0±0.7 0.174
Baseline FVR, mlL/min/mm Hg per 100 mL 30.3±4.9 28.4±3.3 0.108
Baseline venous PAI-1 antigen, ng/mL 10.4±2.5 4.4±1.4 0.001
Baseline venous t-PA antigen, ng/mL 7.5±1.3 5.5±0.6 0.022
Baseline venous t-PA activity, IU/mL 0.6±0.1 0.7±0.1 0.415

FBF indicates forearm blood flow; FVR, forearm vascular resistance; PAI-1, plasminogen activator inhibitor-1; t-PA, tissue-type plasminogen activator.